Literature DB >> 10383552

Paediatric prescribing: using unlicensed drugs and medicines outside their licensed indications.

J Collier.   

Abstract

Mesh：

Year:  1999        PMID： 10383552      PMCID： PMC2014867          DOI： 10.1046/j.1365-2125.1999.00983.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  6 in total

1.  Status of new medicines approved by the European Medicines Evaluation Agency regarding paediatric use.

Authors:  P Impicciatore; I Choonara
Journal:  Br J Clin Pharmacol       Date:  1999-07       Impact factor: 4.335

2.  Regulations requiring manufacturers to assess the safety and effectiveness of new drugs and biological products in pediatric patients--FDA. Final rule.

Authors: 
Journal:  Fed Regist       Date:  1998-12-02

3.  Unlicensed and off label drug use in neonates.

Authors:  S Conroy; J McIntyre; I Choonara
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-03       Impact factor: 5.747

Review 4.  Prescribing unlicensed drugs or using drugs for unlicensed indications.

Authors: 
Journal:  Drug Ther Bull       Date:  1992-12-07

5.  Unlicensed and off label drug use in paediatric wards: prospective study.

Authors:  S Turner; A Longworth; A J Nunn; I Choonara
Journal:  BMJ       Date:  1998-01-31

6.  Use of "off-label" and unlicensed drugs in paediatric intensive care unit.

Authors:  S Turner; A Gill; T Nunn; B Hewitt; I Choonara
Journal:  Lancet       Date:  1996-02-24       Impact factor: 79.321
  6 in total
  18 in total

Review 1.  Drug trials in children: problems and the way forward.

Authors:  S Conroy; J McIntyre; I Choonara; T Stephenson
Journal:  Br J Clin Pharmacol       Date:  2000-02       Impact factor: 4.335

2.  Off label prescribing to children in primary care in Germany: retrospective cohort study.

Authors:  Reinhild Bücheler; Matthias Schwab; Klaus Mörike; Bernhard Kalchthaler; Hartmut Mohr; Helmut Schröder; Peter Schwoerer; Christoph H Gleiter
Journal:  BMJ       Date:  2002-06-01

3.  Antibiotic prescribing for children. Too much and too little? Retrospective observational study in primary care.

Authors:  Suzie Ekins-Daukes; James S McLay; Michael W Taylor; Colin R Simpson; Peter J Helms
Journal:  Br J Clin Pharmacol       Date:  2003-07       Impact factor: 4.335

4.  Inter- and intra-rater reliability for classification of medication related events in paediatric inpatients.

Authors:  D L Kunac; D M Reith; J Kennedy; N C Austin; S M Williams
Journal:  Qual Saf Health Care       Date:  2006-06

Review 5.  Off licence and off label prescribing in children: litigation fears for physicians.

Authors:  P Hill
Journal:  Arch Dis Child       Date:  2005-02       Impact factor: 3.791

6.  Changes in availability of paediatric medicines in Australia between 1998 and 2002.

Authors:  Jocelyn Chui; June Tordoff; David Reith
Journal:  Br J Clin Pharmacol       Date:  2005-06       Impact factor: 4.335

7.  Off-label and unlicensed prescribing for children: have we made any progress?

Authors:  D G Waller
Journal:  Br J Clin Pharmacol       Date:  2007-07       Impact factor: 4.335

Review 8.  Paediatric pharmacokinetics and drug doses.

Authors:  Kate O'Hara
Journal:  Aust Prescr       Date:  2016-12-05

9.  Licence to save: a UK survey of anti-VEGF use for the eye in 2015.

Authors:  A K Shalaby; K Lewis; K Bush; P R Meredith; S Di Simplicio; A J Lockwood
Journal:  Eye (Lond)       Date:  2016-08-12       Impact factor: 3.775

10.  Off-label drug use in a Pediatric Intensive Care Unit.

Authors:  S B Bavdekar; Pranjali A Sadawarte; Nithya J Gogtay; Surabhi S Jain; Sandhya Jadhav
Journal:  Indian J Pediatr       Date:  2009-11       Impact factor: 1.967
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.